As part of its hormone-independent prostate cancer promoting effect, the natural HDAC inhibitor trichostatin A (TSA) increased the transcriptional activity of NF-κB in PC3M prostate cancer cells associated with upregulation of fibrose growth factor FGF8[44]. The gene discussed is HDAC9; the disease is prostate cancer.